Orange Book product · Generic (ANDA)
AVERI
DESOGESTREL; ETHINYL ESTRADIOL
At a glance
May 02, 2025
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
May 02, 2025
1 yr 2 mo ago
Today
Pharmaceutical detail
Active ingredient
DESOGESTREL; ETHINYL ESTRADIOL
Strength
0.15MG;0.03MG
Dosage form
TABLET
Route
ORAL-21
TE code
Not listed
Application
ANDA 218933
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of DESOGESTREL; ETHINYL ESTRADIOL
- 2000CYCLESSABrand (NDA)
NDA 021090 · ASPEN GLOBAL INC
- 1998MIRCETTEBrand (NDA)
NDA 020713 · TEVA BRANDED PHARM
- 1992ORTHO-CEPTBrand (NDA)
NDA 020301 · JANSSEN PHARMS
- 1992DESOGENBrand (NDA)
NDA 020071 · ORGANON USA INC
- 2026DESOGESTREL AND ETHINYL ESTRADIOLGeneric (ANDA)
ANDA 219761 · ANNORA PHARMA
- 2018DESOGESTREL AND ETHINYL ESTRADIOLGeneric (ANDA)
ANDA 207067 · NAARI PTE
- 2017DESOGESTREL AND ETHINYL ESTRADIOLGeneric (ANDA)
ANDA 209170 · NAARI PTE
- 2017KALLIGAGeneric (ANDA)
ANDA 207081 · AUROBINDO PHARMA
- 2017SIMLIYAGeneric (ANDA)
ANDA 206853 · AUROBINDO PHARMA
- 2016VOLNEAGeneric (ANDA)
ANDA 202689 · XIROMED
- 2015BEKYREEGeneric (ANDA)
ANDA 202226 · LUPIN
- 2015ISIBLOOMGeneric (ANDA)
ANDA 202789 · XIROMED
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
